New scalp treatment for hair loss under study
NCT ID NCT07402330
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a drug called DA-020 in 60 healthy women aged 18-55. The goal is to measure how much of the drug enters the blood after one application to the scalp and to check for side effects like blood pressure changes. This research helps understand the drug's safety before testing it in people with hair loss from chemotherapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY SIDE EFFECTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Hospital Samel
Manaus, Brazil
Contact Email: •••••@•••••
-
University of Rome ("G. Marconi")
Rome, Italy
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A web program may ease the emotional toll of chemotherapy hair loss
- Could red light help breast cancer survivors regrow hair after chemo?
- Rectal cancer breakthrough: could a new drug combo save your rectum?
- Exercise app trial aims to unlock Chemo-Brain relief for cancer survivors
- Cool cap could keep hair on during chemo
- Light helmet shows promise for chemo hair loss